 | Up a level |
2022
Fowler, Nathan Hale, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason 
ORCID: 0000-0002-6422-4404, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie Jose, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Perez-Simon, Jose Antonio, Chen, Andy, I, Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andres Jose Maria, Teshima, Takanori, Patten, Piers E. M., McGuirk, Joseph P., Petzer, Andreas L., Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Masood, Aisha, Anak, Oezlem, Schuster, Stephen J. and Thieblemont, Catherine
(2022).
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
Nat. Med., 28 (2).
S. 325 - 343.
BERLIN:
NATURE PORTFOLIO.
ISSN 1546-170X
Salles, Gilles ORCID: 0000-0002-9541-8666, Schuster, Stephen J., Dreyling, Martin, Fischer, Luca ORCID: 0000-0003-2444-416X, Kuruvilla, John, Patten, Piers E. M., von Tresckow, Bastian, Smith, Sonali M., Jimenez-Ubieto, Ana ORCID: 0000-0003-0892-8682, Davis, Keith L., Anjos, Carla, Chu, Jufen, Zhang, Jie, Bodoni, Chiara Lobetti, Thieblemont, Catherine, Fowler, Nathan H., Dickinson, Michael, Martinez-Lopez, Joaquin, Wang, Yucai and Link, Brian K.
(2022).
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma.
Blood Adv., 6 (22).
S. 5835 - 5844.
AMSTERDAM:
ELSEVIER.
ISSN 2473-9537